Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
61186372NSC2007
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Adult (18-64)
Older adult (65+)
EA1181
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Adult (18-64)
Older adult (65+)
EAQ202
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Adult (18-64)
NCI-2019-07941
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Adult (18-64)
Older adult (65+)
HHRA-HS-Phase1-2019
The Heartland Study
Adult (18-64)
Older adult (65+)
NCI-2014-01509
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Adult (18-64)
Older adult (65+)
NCI-2014-02674
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Adult (18-64)
Older adult (65+)
OCU410-101
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Adult (18-64)
Older adult (65+)
201707130
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Adult (18-64)
Older adult (65+)
NCI-2020-05659
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Adult (18-64)
Older adult (65+)